Abstract:569 Background: Obesity, a prominent issue in global health, is known to increase the risk factors associated with a variety of cancers, including hepatocellular carcinoma (HCC), the most common type of primary liver cancer. While existing research affirms the heightened risk of developing HCC in individuals with obesity, there remains a significant gap in understanding the specific influences of obesity on the outcomes of patients admitted with primary HCC diagnosis during their index hospital admission. This study explores the mortality rate, length of stay (LOS), and healthcare utilization in HCC patients with and without obesity. Methods: Nationwide Inpatient Sample (NIS) was queried to determine adult hospitalized patients with a primary diagnosis of HCC using ICD-10 codes. The primary outcome was defined as the effect of obesity on inpatient mortality in those patients. Secondary outcomes included LOS, total hospital charge, health care utilization, ICU admission. We evaluated the baseline characteristics using the t-test and chi-square test. Multivariable logistic regression analysis was performed to assess the association of HCC with obesity and inpatient mortality adjusted by age, gender, race, Charlson index, insurance, and household income. Results: A total of 62,050 HCC patients were identified, and 10.9% of these patients had obesity. HCC patients with obesity were younger (64.7 vs. 65 years, p=0.220), more likely to be female (32.2% vs. 24%, p < 0.001), White (59.8% vs. 50.2% p < 0.001), and more likely to have no insurance (28.8% vs. 23.3%, p < 0.001) compared to HCC patients without obesity. HCC with obesity had higher mean Charlson Comorbidity index 5.9 vs. 5.5, p < 0.001). The overall inpatient mortality rate was 8.2% for all patients who are admitted for HCC; lower in HCC with obesity (5.6%) vs HCC without obesity (8.5%) (p < 0.001). Charlson index, Male gender, African–American race, Hospital teaching status, insurance status found to be associated with inpatient mortality among HCC hospitalizations. HCC with obesity had a lower odds ratio with decreased all-cause mortality of 25% compared to HCC without obesity (aOR 0.75, 95% CI 0.58-0.96, p = 0.023). In addition, HCC with obesity was associated with increased LOS mean 6.3 vs. 5.7 days (adjusted difference: 0.6 p < 0.001), and total hospital charges (mean 88,481, adjusted difference: $21122 p < 0.0001). Also; ICU transfer rate and AKI development were found more in obese cohort and this different was statistically significant. Conclusions: Our study revealed that HCC patients with obesity had a lower inpatient mortality rate compared to those without obesity, despite longer hospital stays and higher costs. These findings hint at a complex interplay between obesity and HCC outcomes, necessitating further in-depth research.

S204 Impact of Bariatric Surgery and Obesity on Hospitalized Patients With Gallstone Disease: A National Inpatient Sample Analysis

The impact of bariatric surgery on admissions for gastrointestinal complications and conditions associated with obesity: A nationwide study

The impact of obesity on postoperative outcomes following surgery for colorectal cancer: analysis of the National Inpatient Sample 2015–2019

Analysis of postoperative emergency admission and hospitalization of patients who underwent bariatric surgery: A single-center experience

Bariatric Surgery Outcomes in Patients with Inflammatory Bowel Disease in the United States: An Analysis of the Nationwide Readmissions Database

Path Analysis of the Impact of Obesity on Postoperative Outcomes in Colorectal Cancer Patients: A Population-Based Study

S117 Nationwide Burden and Trend of Gallbladder and Biliary Disease Attributable to High BMI in the Last 3 Decades: Secondary Analysis for the Global Burden of Disease Study 2021

S973 Acute Gastrointestinal Bleed in Bariatric Surgery Patients: A Nationwide Population Based Study

Effect of obesity on perioperative outcomes following gastrointestinal surgery: meta-analysis

The Influence of Obesity on Cholecystectomy Outcomes: A Systematic Review of Laparoscopic and Open Approaches

S2091 Outcomes of Alcohol-Associated Hepatitis in Hospitalized Patients With Prior Bariatric Surgery: A Nationwide Analysis, 2016-2020

S2108 A Comparative Study on Symptomatic Gallstones: The Impact of Rapid Weight Loss From Bariatric Surgery Versus GLP-1 Agonist Treatment

S1745 Impact of Metabolic and Obesity Phenotypes on Outcomes in Patients With MASLD: Insights From National Inpatient Sample

Impact of opioid-related disorders on complications in patients undergoing bariatric surgery: a propensity score-matched analysis of the national inpatient sample

The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery—An International Expert Survey

Impact of bariatric surgery on gut microbiota composition in obese patients compared to healthy controls

The Effect of Bariatric Surgery on the Composition of the Gut Microbiota Community: an Imbalance Associated with Severe Disorders

Reduction of cardiovascular complications during delivery hospitalization in patients undergoing bariatric procedures

The Impact of COVID-19 Pandemic on Patient Selection and Access to Care, Approach Type, and Postoperative Outcomes in Bariatric Surgery

Relationship between obesity severity and Helicobacter pylori eradication in patients undergoing bariatric and metabolic surgery: A post hoc analysis

The effect of obesity in hospitalized patients with hepatocellular carcinoma: A nationwide analysis.